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Regulation of chaperone function by coupled folding 
and oligomerization
Guillaume Mas, Björn M. Burmann*, Timothy Sharpe, Beatrice Claudi,  
Dirk Bumann, Sebastian Hiller†
The homotrimeric molecular chaperone Skp of Gram-negative bacteria facilitates the transport of outer membrane 
proteins across the periplasm. It has been unclear how its activity is modulated during its functional cycle. Here, 
we report an atomic-resolution characterization of the Escherichia coli Skp monomer-trimer transition. We find 
that the monomeric state of Skp is intrinsically disordered and that formation of the oligomerization interface 
initiates folding of the -helical coiled-coil arms via a unique “stapling” mechanism, resulting in the formation of 
active trimeric Skp. Native client proteins contact all three Skp subunits simultaneously, and accordingly, their 
binding shifts the Skp population toward the active trimer. This activation mechanism is shown to be essential 
for Salmonella fitness in a mouse infection model. The coupled mechanism is a unique example of how an ATP- 
independent chaperone can modulate its activity as a function of the presence of client proteins.
INTRODUCTION
Molecular chaperones are central for the survival of the cell in all 
kingdoms of life (1–2). They are involved in many cellular processes 
such as helping proteins to fold, preventing protein aggregation, and 
reducing cellular stress (3). Some chaperones can use adenosine tri-
phosphate (ATP) binding and hydrolysis to trigger conformational 
changes that, in turn, regulate their functional cycle, including their 
interaction with client proteins (4). ATP-independent chaperones, 
in turn, lack this possibility. Nonetheless, some ATP-independent 
chaperones were found to be regulated by major conformational 
changes, and the transition mechanisms for the activation of ATP- 
independent chaperones have been classified into three categories (5): 
oligomer disassembly [small heat shock protein (sHSP) (6) and trigger 
factor (TF) (7–9)], order-to-disorder transition {Hsp33 (10), HdeA 
[HNS (histone-like nucleoid structuring)–dependent expression A] 
(11), and HdeB (12)}, and lack of major conformational change 
[spheroplast protein Y (Spy) (13, 14), seventeen kilodalton protein 
(Skp) (15), HSP40 (16), SecB (17), and survival factor A (SurA) (18)]. 
These mechanisms of activation are of major biological importance, 
because constitutively active chaperones can interfere with protein 
folding processes and proteostasis due to their high affinity and low 
specificity for client proteins, thus representing a potential hazard 
to cells (19–22). An example of these detrimental effects has been 
reported for a constitutively active variant of the chaperone Hsp33, 
which lead to accumulation of large amounts of insoluble aggregates 
and severe growth disadvantages (20).
Representative of the first category, binding of chaperone sHSP 
to its client proteins is regulated via a shift from an inactive oligomeric 
ensemble toward an ensemble of smaller multimers, representing 
the active species (6). The monomeric species exposes a binding 
motif that is shielded within the oligomeric structure, making the 
large oligomeric state an inactive storage form that can be activated 
upon dissociation (23, 24). Similarly, it has been shown that binding 
of TF to client proteins is accompanied by a shift from the inactive 
dimeric state toward the active monomeric state (7–9). By contrast, 
the order-to-disorder activation is found for chaperones where the 
active form is intrinsically disordered. Thereby, to shift from the 
folded inactive chaperone to the unfolded active chaperone, not 
only the oligomeric state but also the secondary structure of the 
chaperone is undergoing change, triggered either by a pH drop to 
acidic conditions (HdeA and HdeB) or by a redox transition (Hsp33). 
Once stress factors are reduced, these chaperones can return to their 
folded/oligomeric inactive state with a release of the client (25). The 
third category contains chaperones for which only one conforma-
tional state is known, and therefore, these are assumed to require no 
major conformational changes for their activation, as well as 
chaperones for which activation requires only minor conformation-
al changes. One such example is provided by the chaperone Hsp40, 
which has minimal structural differences between its client-bound 
and apo state (16). Another example is given by the chaperone SecB, 
for which high-resolution structures of client-bound states showed 
only a minor conformational change to the inactive client-free state 
(17). In the client-free form, helix 2 acts as a lid of the client pro-
tein binding site. Upon client binding, this helix swings outward, 
thereby allowing access to the client binding groove. Similarly, the 
chaperone SurA has been shown to have a dynamic mechanism of 
activation where a domain connected to the chaperone core by 
linkers assists client protein recognition, binding, and release (18).
The periplasmic chaperone Skp is an integral part of outer mem-
brane protein (Omp) biogenesis, on a parallel pathway with the 
chaperone SurA. Skp transports Omps in their unfolded state across 
the periplasm toward their insertion point into the outer membrane 
(26–28). Yersinia skp and Salmonella skp mutants show compro-
mised virulence in rodent infection models, indicating a crucial role 
of Skp in vivo (29, 30). Skp is structurally characterized by a trimeric 
oligomeric state with a “jellyfish”-like architecture (31, 32). Each 
protomer contributes three -strands toward a nine-stranded -barrel 
in the trimerization interface and a long, -helical “arm,” made of 
two -helices in coiled-coil arrangement (31, 32). The combination 
of three arms from the individual subunits leads to formation of a 
cavity that can accommodate and bind unfolded Omps (15, 33).
The elongated arms of Skp are highly flexible in the apo state, and 
a recent molecular dynamics study has identified a pivot element to 
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act as a hinge, allowing Skp to adapt to clients of different sizes 
(15, 34). Upon binding, the Skp arms undergo a rigidification and 
keep the bound Omps inside the cavity in the “fluid globule” state 
(15, 35). While Skp can accommodate differently sized protein clients, 
all functional complexes observed so far feature an Omp:Skp 
stoichiometry of 1:3 or 1:6, depending on the size of the client, suggest-
ing that Skp binds clients always as a trimer (36). A recent study 
has emphasized that at physiological concentrations, Skp exists as an 
equilibrium between a trimeric and a monomeric form (37). The equi-
librium was quantified by analytical ultracentrifugation (AUC), showing 
that the monomeric form is strongly dominant at 2 M Skp, the 
concentration found in Escherichia coli stationary phase (38, 39). 
The monomeric form of Skp has been proposed to be well folded 
based on indirect evidence (37); however, it has so far not been pos-
sible to directly analyze its structure, because at the high concentration 
required for most biophysical methods, the protein is mostly trimeric. 
Consequently, the structural features of the Skp monomeric state 
and the Skp activation mechanism remain poorly understood.
Here, we bypass this analytical challenge by introducing several 
weakly and non-oligomerizing mutants of Skp. We characterize their 
monomeric states by solution nuclear magnetic resonance (NMR) 
spectroscopy at the atomic level. The emerging reference data can then 
be used to fruitfully understand monomeric Skp(WT). The data show that 
monomeric Skp is intrinsically disordered and inactive and that bind-
ing of a client protein triggers Skp trimerization and activation. Last, 
we demonstrate that this mechanism is essential for bacterial virulence 
under in vivo conditions in a mouse infection model. The data thus 
reveal an essential mechanism regulating Skp chaperone activity by 
a combined disorder-to-order and oligomerization transition.
RESULTS
Design of monomeric Skp mutants
To prepare samples of monomeric Skp at concentrations sufficient 
for structural characterization, we set out to design mutants that would 
destabilize the oligomerization interface to shift the oligomerization 
equilibrium toward the monomeric form. The structure of trimeric 
Skp is stabilized by a network of three -sheets per subunit that to-
gether form the trimerization interface in the “head” of the molecule 
(Fig. 1A). We identified the conserved alanine-103 and alanine-108 
as promising candidates, because they are located at the oligomeri-
zation interface with limited space for their side chains. Their re-
placement by a bulkier side chain such as leucine or arginine should 
introduce steric clashes, leading to destabilization of the trimer 
Fig. 1. Identification of Skp mutations that perturb the monomer-trimer equilibrium. (A) Location of the mutation sites [red boxes (I), (II), and (III)], displayed on the 
Skp crystal structure (Protein Data Bank: 1SG2). Secondary structure elements and termini are indicated. (B) Close-up of the interface between Skp subunits, highlighting 
the position of the five mutations. See text for details. (C) SEC elution profiles (solid lines, left axis) and MALS apparent molecular mass (MM) (dotted lines, right axis) at 
elution concentrations of ≃80 M and a temperature of 25°C. Dark gray, Skp(WT); brown, Skp(A103L); green, Skp(A103R); blue, Skp(A108L); magenta, Skp(A108R); purple, 
Skp(V117P). Gray horizontal lines indicate the molecular masses of monomers, dimers, and trimers of Skp. (D) Experiment as in (C) for Skp(A108L) as a function of the 
elution concentrations: 5, 20, and 79 M. (E) Fractional populations f of monomers in the monomer-trimer equilibrium as a function of total Skp concentration. Experi-
mental data points from NMR and SEC-MALS are indicated by filled and open circles, respectively. These have been fitted by Eq. 4 for mutants A103R and A108L (solid 
lines). The corresponding fractional populations of the trimeric state, 1 − f, are shown by dashed lines. Note that the concentration of Skp trimers equals one-third of the 
concentration of Skp molecules in the trimeric state, i.e., [Skp]trimer = 1/3 · (1 − f) · [Skp]tot. For Skp(WT) and Skp(A103L), the data follow the WT association constant pub-
lished by Sandlin et al. (37).
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(Fig. 1, A and B). In addition, we designed the mutant V117P to 
insert a proline residue, which is a known secondary structure breaker, 
into the trimerization -sheet (2). The oligomerization state of each of 
the Skp mutants Skp(A103L), Skp(A103R), Skp(A108L), Skp(A108R), 
and Skp(V117P) was determined by SEC-MALS (size-exclusion 
chromatography coupled to multi-angle light scattering) experiments 
at an elution concentration of ≃80 M. At this concentration, the 
wild-type (WT) protein is mostly trimeric with a monomeric fraction 
lower than 4%. The mutant A103L was hardly distinguishable from 
WT, but the other Skp variants featured a gradually increased mono-
meric fraction, as evidenced by a smaller apparent mass, in the order 
A103R, A108L, V117P, and A108R (Fig. 1C). Thereby, mutants A108R 
and V117P were fully monomeric, and the others had effective molecu-
lar weights in between monomer and trimer, suggesting the presence 
of dynamic equilibria. We quantified the concentration dependence of 
these equilibria for Skp(A103L), Skp(A103R), and Skp(A108L) by 
solution NMR spectroscopy and SEC-MALS experiments (Fig. 1, C to E; 
Table 1; and fig. S1). Skp(WT) followed an equilibrium with C0.5 = 
1.5 M, the protein concentration at which half of the molecules are in 
the monomeric form, in agreement with published data (37). Skp(A103L) 
showed a trimer-monomer equilibrium that was essentially identical 
to WT (Fig. 1E and fig. S1), whereas Skp(A103R) had C0.5 = 7 ± 2 M 
and Skp(A108L) had C0.5 = 80 ± 20 M, indicating that these mutations 
shifted the equilibrium by about one to two orders of magnitude to-
ward the monomer (Fig. 1, D and E, and fig. S1). The two mutants 
Skp(A108R) and Skp(V117P) were found to be monomeric at 
concentrations of even up to 1 mM (Fig. 1E and fig. S1).
We then characterized the structural integrity of Skp(A103L), 
Skp(A103R), and Skp(A108L) in their trimeric forms by NMR 
spectroscopy. For each of these proteins, two-dimensional (2D) 
[15N,1H]-TROSY (transverse relaxation-optimized spectroscopy) fin-
gerprint spectra show the presence of two species in slow exchange on the 
NMR time scale, i.e., with kinetic exchange rate constants kex ≤ 10 s−1 
(fig. S1). For each of the mutants, the overlay of the NMR spectra 
at 25°C (fig. S2) shows a high degree of similarity with the WT pro-
tein for most resonances, with considerable chemical shift perturba-
tions only for some residues. Those residues are all located in spatial 
vicinity of the mutation site, in full agreement with the expected 
local distortion effects of single point mutations (fig. S2). The signals 
of residues located in the arms are not affected by the mutations, 
suggesting that symmetry and structural integrity of the trimeric 
form of the protein are maintained in the mutant. Oligomeric 
states other than the monomer and the trimer were not detected. The 
mutations thus shift the oligomerization equilibrium while leaving 
the trimeric form largely intact.
Monomeric Skp is intrinsically disordered
The mutant Skp(A108L) with a C0.5 of 80 ± 20 M at 25°C allowed 
us to prepare the monomeric state at concentrations of 100 M and 
above, which is required for solution NMR spectroscopy. The NMR 
spectra of monomeric Skp(A108L) are completely overlapping with 
the monomeric, but low-abundant conformation of Skp(WT) (Fig. 2A), 
indicating that the conformations are essentially identical and thus 
validating the further analysis. Increasing the temperature from 25° 
to 37°C shifted the equilibrium of Skp(A108L) further toward the 
monomer, resulting in around 95% monomer at a concentration of 
1 mM and thus further increasing the NMR signal intensity (fig. S2). 
A primary classification of the type of conformational state of mono-
meric Skp was obtained from the observation of a narrow chemical 
shift dispersion of backbone amide NMR signals, which is charac-
teristic for proteins with low structural propensity (fig. S3). To 
quantify the secondary structure elements, we established complete 
sequence-specific resonance assignments of the monomeric state 
(fig. S3) and determined backbone 13C and 13C secondary chemical 
shifts (Fig. 2B). These show that the three -sheets that constitute 
the oligomerization interface in the trimeric form are in random- 
coil conformation in the monomeric state. Furthermore, the four 
-helices forming the arms of Skp are in a fast conformational ex-
change between folded and unfolded conformations, as evidenced 
by the observation of a single set of resonances in fast exchange. 
Taking the fully denatured form of Skp in 8 M urea solution and the 
folded trimer as reference points, the residual helicity can be quan-
tified for each residue (Fig. 2, B and C). The analysis shows that 
the helices 1, 3.B, and 4, which are closest to the trimerization 
interface, feature a residual helicity of <20%, while the helices 2.A, 
2.B, and 3.A located at the tip of the arms display a helical popu-
lation of 20 to 30% (Fig. 2, C and D). Overall, these data show that a 
small amount of residual -helical structure is present in the disor-
dered Skp monomers, but that the complete formation of the helices 
requires the trimerization interface. Overall, these data demonstrate 
that the monomeric state of Skp is intrinsically disordered with some 
residual helical propensity located at the tip of the arms. In the trimeric 
structure, the circular-barrel interface, connecting the N- and C- 
terminal part of the protein, brings helices 2 and 3 close together 
Table 1. Biophysical and in vivo properties of Skp variants. Error estimates have been omitted for clarity. n.d., not determined. 
C0.5 (M)
Skp activity (% of 
WT)
Trimer (%) at 
c ≃ 80 M
Monomer (%) at 
c ≃ 80 M
Salmonella fitness 
in rich LB (% of 
WT)
Salmonella fitness 
in mouse infection 
model (% of WT)
Skp(WT) 1.5 100 97 3 100 100
Skp(A103L) 1.5 100 94 6 106 92
Skp(A103R) 7 87 86 14 102 58
Skp(A108L) 80 55 47 53 n.d. n.d.
Skp(A108R) >1000 1 0 100 n.d. n.d.
Skp(V117P) >1000 1 0 100 102 54
Skp – – – – 104 54
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in space and thus stabilizes their secondary structure (Fig. 2E). This 
unique mechanism resembles a “stapling” of the coiled-coil helices 
to the barrel in the head domain.
It has been previously proposed that the monomeric state of Skp 
would be well folded rather than disordered (37). That conclusion 
was obtained from indirect measurements of the molar heat capacity 
change Cp of trimer formation by a van’t Hoff analysis of temperature- 
dependent AUC data, which indicated a value of Cp = −0.62 ± 0.11 kcal 
mol−1 K−1 for the Skp monomer-trimer transition. Because the au-
thors expected a value for a coupled folding and oligomerization of 
Cp = −8.01 ± 3.3 kcal mol−1 K−1, they concluded that only trimeriza-
tion, but not folding, would take place during oligomerization. To 
resolve these different views, we determined Cp of Skp(WT) directly 
by differential scanning calorimetry (DSC) to Cp = −2.9 ± 0.4 kcal 
mol−1 K−1 at 37°C (fig. S3). Considering the average residual helicity 
of 21% in the monomer, this corresponds to a value of −1.1 kcal 
mol−1 K−1 for folding of one monomer subunit, which is a similar 
value to proteins of the same size (40, 41). We note that Cp is strongly 
temperature dependent (fig. S3), which may have perturbed the pre-
cision of the van’t Hoff analysis by Sandlin et al. (37).
Omp binding stabilizes the functional Skp trimer
Having established that Skp activation comprises an equilibrium 
between a folded trimer and a disordered monomer, it appears rel-
evant to understand how this equilibrium contributes to Skp chap-
erone activity. As a model client, we use the native client protein 
tOmpA, an eight-stranded transmembrane domain of OmpA. 
tOmpA, when bound to Skp, adopts a conformational ensemble of 
rapidly reorienting conformers (15). To investigate whether tOmpA 
binds to the trimeric or the monomeric state of Skp, or to both, we 
used an activity assay with all mutants. In a first step, we measured 
the chaperone activity by quantifying the amount of Skp-bound 
tOmpA. Intriguingly, the activity correlated with the concentration 
of the trimer for all Skp variants, such that, e.g., Skp(A108L) has 
around 50% of the Skp(WT) activity and that no chaperone activity 
could be detected for Skp(V117P) and Skp(A108R) (Fig. 3, A and B, 
and fig. S4).
We then selected Skp(A108L) to characterize structure and ar-
rangement of the tOmpA-Skp(A108L) complex. First, addition of 
tOmpA to Skp(A108L) increases the apparent molecular mass in 
SEC-MALS experiments (fig. S4). Second, the 2D [15N,1H]-TROSY NMR 
Fig. 2. Monomeric Skp is intrinsically disordered. (A) Sections of 2D [15N,1H]-TROSY spectra of [U-2H,15N] Skp(WT) (dark gray) and Skp(A108L) (blue) at a concentration 
of 1 mM and 37°C in NMR buffer (20 mM MES, pH 6.5, and 150 mM NaCl). NMR signals of the monomeric state of Skp(WT) are overlaying with the one from Skp(A108L). 
The assignments of the overlapping NMR signals of the monomeric state are indicated in the panel. (B) Residue-specific secondary backbone chemical shifts of Skp(WT) 
in 8 M urea solution, Skp(A108L) in its monomeric form, and Skp(WT) in its trimeric form. Positive and negative values indicate -helical and -sheet secondary structure 
elements, respectively. The gray-shaded area indicates the positions of helices in the Skp trimer. (C) Percentage of helical population in the conformational ensemble of 
the Skp monomer. Helical regions with 10 to 20% helicity or 20 to 30% helicity are highlighted with light or dark yellow, respectively. (D) Structural model of the Skp 
monomer. On a configuration of Skp with -helices formed, the degree of residual helical population present in the conformational ensemble is indicated. The large 
majority of monomeric Skp is disordered. (E) Schematic model of coupled oligomerization and folding mechanism of Skp. Monomeric Skp explores an ensemble of con-
formations with a low propensity for the formation of the arm -helices. The formation of the oligomerization interface brings the N and C termini together (red arrows), 
thus stabilizing the coiled-coil structure of the -helical arms.
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spectra of isotope-labeled tOmpA bound to unlabeled Skp(A103L), 
Skp(A103R), Skp(A108L), or unlabeled Skp(WT) are highly similar 
(Fig. 3B and fig. S4). Because the chemical shift is a population- 
weighted average over the individual conformers in the tOmpA en-
semble, this observation indicates that the client conformational 
ensemble inside the chaperone is essentially unperturbed by the local 
structural adaptations, resulting from the mutation A103L, A103R, 
or A108L. Third, a direct spectral comparison showed that the chemical 
shift perturbations that occur on the Skp trimeric state upon tOmpA 
binding are highly similar for Skp(WT), Skp(A103L), Skp(A103R), 
and Skp(A108L) (Fig. 3, C and D, and fig. S4). Identically to the apo 
state, only one set of NMR signals is present for the trimeric state, 
showing that the complex with tOmpA does not involve other stable 
oligomeric states (Fig. 4, D to G). Furthermore, for all mutants with 
a considerable population of the trimeric state, binding of tOmpA 
induces similar chemical shift perturbations, confirming a similar mode 
of binding (Fig. 3, C and D, and fig. S3). As a consequence, the struc-
tural description that was previously established for the Skp-tOmpA 
complex (15) can be assumed in good first-order approximation also 
for Skp(A108L), although the thermodynamics and kinetic of the 
ensemble are somewhat different (Fig. 3, B to D).
Then, we investigated the effect of tOmpA binding on the Skp 
monomer-trimer equilibrium at a temperature of 37°C, where 
Skp(A108L) is more than 80% in its monomeric state and Skp(A108R) 
and Skp(V117P) are completely monomeric (Fig. 3, E and F, and fig. S4). 
For Skp(A108L), binding of tOmpA resulted in a strong shift of the 
population levels from the monomeric toward the trimeric state, 
while no change was observed for Skp(A108R) and Skp(V117P) 
Fig. 3. Client binding promotes Skp oligomer assembly. (A) Holdase activity of Skp variants as determined by the amount of aggregation-prone tOmpA solubilized in 
equilibrium. Values are normalized to the activity of Skp(WT). Error bars represent the SD of 15 individual signals of tOmpA. (B) 2D [15N,1H]-TROSY fingerprint spectra of 
[U-2H,15N]-tOmpA bound to unlabeled Skp(WT) or Skp(A108L). Spectra were recorded at a temperature of 37°C in NMR buffer (20 mM MES, pH 6.5, and 150 mM NaCl). A 
1D 1H cross section shows the intensity of alanine-176. (C) Combined amide chemical shift differences between [U-2H,15N]-Skp(WT) and [U-2H,15N]-Skp(A108L) with bound 
unlabeled tOmpA. The magnitude of 2 SDs [0.053 parts per million (ppm)] is indicated by a dashed line. (D) Structural model of Skp(108L) with bound tOmpA. Amide 
groups with chemical shift changes larger than 2 SDs upon binding of tOmpA to Skp(A108L) are marked in light blue. The position of A108 is indicated by a blue circle. 
(E and F) 2D [15N,1H]-TROSY fingerprint spectra of [U-2H,15N] Skp(A108L) in the absence (E) and presence (F) of unlabeled tOmpA. Spectra were recorded at 37°C in NMR 
buffer. The spectral area 7.5 to 8.5 ppm in 1H, corresponding to disordered protein states, is indicated by gray lines. 1D 1H cross sections of lysine-141 in the monomeric 
(M) and trimeric (T) state of Skp are shown, and the relative fractions are indicated.
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(Fig. 3, E and F, and fig. S4). Furthermore, for all Skp variants with 
considerable population of the monomeric state, the NMR signal 
positions of the monomeric state were not perturbed by the addi-
tion of tOmpA, confirming that there is no detectable interaction 
between monomeric Skp and the Omp client (fig. S3). This is an 
additional proof that only the structured trimer, but not the disor-
dered monomer, has chaperone activity.
Because a bound tOmpA client is in direct contact with all three 
arms of Skp simultaneously (15), client binding contributes by avidity 
to the thermodynamic stability of the trimeric state of the chaperone. 
We quantified the difference in free energy of apo-Skp(WT) in com-
parison to tOmpA-Skp(WT) by a denaturation titration (fig. S4). 
Binding of tOmpA to Skp(WT) increased its stability by 1.7 kJ mol−1, 
corroborating the stabilization effect of the trimeric state by the bind-
ing of its client protein. Overall, the data show that monomeric, dis-
ordered Skp does not interact with the Omp client and that client 
binding increases the stability of the Skp trimer by avidity, thus 
shifting the conformational equilibrium toward the trimeric state.
Relevance of the Skp activation mechanism 
for bacterial virulence
Skp is dispensable for growth of various bacterial species under rich lab-
oratory conditions. However, bacterial pathogens such as Yersinia 
and Salmonella require Skp for growth in hostile host tissue. To de-
termine whether the Skp activation mechanism that we identified is 
important under these physiologically relevant conditions, we engi-
neered analogous point mutants in Salmonella enterica serovar 
Typhimurium. Salmonella Skp is highly homologous to E. coli Skp, 
with 91% identity (fig. S4). We selected three of the mutations for 
these experiments, the two mildest ones A103R and A103L, as well 
as V117P, and also engineered a strain with complete genetic deletion 
of the skp gene (skp). As expected, neither the point mutants nor 
a full skp deletion affects Salmonella fitness in rich lysogeny broth 
(Fig. 4A and Table 1). We then tested the same mutants in competitive 
infections in a mouse typhoid fever model. In competitive infections, 
mice are infected with a mixture of WT and mutant strains. Plating 
of bacteria retrieved from spleen of these mice yields the fitness of 
mutants relative to the WT bacteria in each mouse. This approach 
reduces interindividual variance and offers higher statistical power 
with limited numbers of experimental animals compared to single- 
strain infections. The data reveal a slight but significant fitness defect 
of Salmonella skp(A103L) compared to WT and strong fitness defects 
for mutants skp(A103R) and skp(V117P), which are comparable to the 
full skp deletion (Fig. 4B and Table 1; competitive index data in fig. 
S4). These results show that already subtle perturbations of the Skp 
monomer-trimer equilibrium diminish Skp function in vivo and that 
perturbation of this equilibrium by less than an order of magnitude in 
C0.5 completely abolishes Skp function, rendering bacteria nonvirulent.
DISCUSSION
In this work, we have elucidated the activation mechanism of the 
molecular chaperone Skp at atomic resolution. The monomer state 
of Skp is intrinsically disordered, with a limited residual propensity 
of -helicity in the coiled-coil tentacle arms. This low inherent sta-
bility of helices 2 and 3 is particularly interesting, because they are 
not involved in inter-subunit contacts in the trimer structure. The 
formation of the head domain trimer merely fixes the positions of 
the end points of the -helices in space, thus stabilizing them by 
reducing the conformational entropy of the unfolded state. This 
unique mechanism resembles a stapling of the coiled-coil helices to 
the barrel in the head domain. A directly related effect is being ex-
ploited in peptide chemistry to stabilize helical conformation of small 
peptides by a suitably chosen covalent circularization, the so-called 
stapled peptides (42). Furthermore, because the tOmpA client is in 
simultaneous direct contact with all three Skp subunits, its binding 
stabilizes and shifts the oligomer equilibrium of Skp toward the trimeric 
state. Last, the disordered Skp monomer does not exhibit chaperone 
activity.
These mechanistic insights integrate into an improved picture of 
the functional cycle of Skp in the bacterial periplasm (Fig. 4C). 
Monomeric, disordered Skp molecules populate the periplasmic space. 
As soon as a client protein emerges from the Sec translocase, the 
inactive monomers fold and assemble into a trimeric state around 
the unfolded client protein. Skp directly or indirectly transports the 
chain to the Bam complex for folding and insertion in the mem-
brane and possibly also to DegP for degradation (27, 43). The exact 
mechanism of client release is not understood, but besides direct 
migration to a higher-affinity target, one exciting possibility to enhance 
the release kinetics could be a destabilization of the oligomeric state 
of Skp or a stabilization of the monomeric state of Skp in the vicinity 
of the downstream receptor of the substrate. This may include 
negative charges on membranes or BamA (36, 44, 45). After client 
release, the disordered Skp monomers enter the periplasmic reservoir 
of individually inactive chaperones. The absence of a chaperoning 
Fig. 4. Essentiality and the functional cycle of the periplasmic chaperone Skp. 
(A) Fitness of Salmonella strains with various chromosomal skp mutations in rich 
lysogeny broth. Data for individual cultures and means are shown. (B) Fitness of 
Salmonella strains in a mouse infection model. Each circle represents data for one 
mouse from a total of two independent infection experiments (****P < 0.0001 and 
***P < 0.001; statistical significance of difference to values for WT based on t test 
with Holm-Šídák correction for multiple comparisons). Corresponding competitive 
index data are shown in fig. S4. (C) Functional cycle of Skp. In the absence of client 
proteins, Skp populates the periplasm in monomeric form up to low micromolar con-
centrations. These partially disordered monomers are functionally inactive. An emerg-
ing Omp client at the inner membrane recruits an active trimeric chaperone from the 
ensemble equilibrium. Upon release of the client, trimeric Skp dissociates and the 
monomers enter the pool of inactive disordered conformations. See text for details.
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activity of the monomer ensures that only Skp molecules with com-
plete cavity bind clients, providing maximal chaperoning effect in 
an all-or-none fashion. At the same time, it introduces a direction-
ality of the chaperoning effect toward the center of the cavity, avoiding 
spurious binding effects that would not be directed into the Skp 
cavity. These could potentially destabilize periplasmic proteins that 
are not intended client proteins. Last, the disordered nature of mo-
nomeric Skp might facilitate its import into the periplasm through 
the Sec complex upon its own biogenesis. Additional impact for this 
type of activation mechanism comes from a direct comparison to 
the activation mechanism of the chaperone SurA (18). SurA is con-
stitutively active with just a dynamic modulation of its activity upon 
rotation of a domain connected by linkers to its chaperone core, i.e., 
its activity is only weakly regulated (18). Skp activity, in turn, is 
strongly regulated, with a switch between a completely inactive and 
an active state, as shown in this work. This stark difference matches 
a fundamental difference in function of these two periplasmic chaper-
ones. Skp has high affinity for its client proteins and a strong ten-
dency to prevent their folding and therefore presumably requires to 
be tightly regulated to avoid unspecific chaperone activity under no- 
stress conditions, whereas SurA binds unfolded OMPs with lower 
affinity while promoting their folding and therefore presumably does 
not require a strong regulation of its chaperone activity (15, 46–49).
The Skp activation mechanism provides an elegant example how 
a chaperone can regulate its functional cycle in an environment de-
pleted of any source of energy. For ATP-independent chaperones, 
only three types of activation mechanisms have so far been de-
scribed: an order-to-disorder transition [Hsp33 (10), HdeA (11), 
and HdeB (12)], oligomer disassembly [sHSP (6) and TF (7–9)], and 
no or minor conformational change [Spy (13, 14), HSP40 (16), SecB 
(17), and SurA (18)]. Skp is the first chaperone found to feature 
these activation mechanisms in the opposite direction and even 
combine them, i.e., by a disorder-to-order transition that is coupled 
to oligomerization. The high (nM)–affinity Skp has for its client 
proteins and the strong tendency to prevent their folding could rep-
resent a potential hazard to the cell (15, 49). The coupled folding 
and oligomerization mechanism ensures that holdase function is only 
present in the trimer where it is geometrically oriented only toward 
the chaperone cavity. Under nonstressed conditions, Skp exists as an 
inactive disordered monomer with a minor population of active folded 
trimer to avoid detrimental effect for the cells. At the opposite, under 
stress conditions, up-regulation of the Skp concentration and binding 
to client proteins shift the equilibrium toward the trimeric folded 
active state, protecting the cells by preventing aggregation of unfolded 
protein. While most chaperones use strategies to cover a preexisting 
client binding site in their inactive state, Skp has thus evolved a more 
extreme mechanism where the client binding area exists only in the 
active state. This strong regulation allows the tight control of Skp 
activity while providing at the same time a fast mechanism for client 
release upon dissociation into the disordered monomeric state. The 
chaperone activity of Skp is thus regulated in dynamic response to 
chaperone concentration and client availability.
MATERIALS AND METHODS
Cloning, expression, and purification of Skp
Skp, lacking its signal sequence, was cloned from genomic DNA through 
Nde I and Xho I into the pET28b expression vector (Novagen) con-
taining a thrombin-cleavable N-terminal His6-tag (15). Skp was ex-
pressed in BL21-( DE3)-Lemo cells [New England Biolabs (NEB)] 
transformed with the Skp plasmid and grown at 37°C in M9 minimal 
medium containing kanamycin (30 mg/ml) to OD600 (optical density 
at 600 nm) = 0.6, and then the expression was induced by adding 
0.4 mM isopropyl--d-thiogalactopyranoside (IPTG) at 25° for 12 hours. 
Uniformly [2H, 13C, 15N]-labeled protein was prepared by growing 
cells in D2O-based M9 minimal medium, with 1 g of 15NH4Cl and 2 g 
of [U-13C,2H] glucose per liter of medium. Cells were harvested by 
centrifugation at 5000g for 20 min. The pellet was resuspended in 
20 ml of lysis buffer A per liter of culture [20 mM tris (pH 7.5), 500 mM 
NaCl, deoxyribonuclease (DNase) (0.01 mg/ml), ribonuclease (RNase) 
(0.02 mg/ml), and inhibitor cocktail (cOmplete EDTA-free protease 
inhibitor; Roche)]. Cell lysis was performed using a microfluidizer 
(Microfluidics) for three cycles at 4°C. The soluble bacterial lysate 
was separated from cell debris and other components by centrifugation 
at 14,000g for 60 min and loaded onto a Ni-NTA (nitrilotriacetic acid) 
column (Qiagen). Skp eluted at 250 mM imidazole concentration 
and was dialyzed against buffer [20 mM tris (pH 7.5) and 500 mM 
NaCl] overnight to remove the imidazole. In a final step, a size ex-
clusion chromatography (Superdex-200 16/600 PG) step was applied 
to further purify the proteins and adjust the protein to its final buffer 
[20 mM MES (pH 6.5) and 150 mM NaCl]. Note that the His6-tag 
was consistently not cleaved from all Skp constructs, because in both 
our hands and published work by others (37), the presence of the 
His6-tag was found to not change the monomer-trimer equilibrium 
constant and because monomeric, disordered Skp was found to be 
sensitive to proteolytic degradation. Afterward, Skp was concentrated 
by ultrafiltration and stored at −20°C until use. Final yield of purified 
protein was 25 mg for Skp(WT) and mutants per liter of deuterated 
M9 minimal medium.
Cloning, expression, and purification of tOmpA
The transmembrane domain of OmpA (residues 1 to 177) was cloned 
through Nco I and Xho I into the pET28b expression vector without 
any affinity tag and lacking its signal sequence (15). BL21-( DE3)- 
Lemo cells (NEB) were transformed with the tOmpA expression plasmid 
and grown at 37°C in medium containing kanamycin (30 g/ml) to 
OD600 = 0.8. Expression was induced by 1 mM IPTG. Cells were 
harvested 4 hours after induction and resuspended in 20 ml of buf-
fer B per liter of culture (20 mM tris-HCl and 5 mM EDTA, pH 8.5). 
Cell lysis was performed using a microfluidizer (Microfluidics) for 
three cycles at 4°C. Purification from inclusion bodies was done 
as described (50). The ion-exchange elution fractions containing 
tOmpA were pooled and dialyzed against buffer B. The precipitate 
was resuspended in 6 M Gdm/HCl and stored at −20°C until usage. 
Final yield of purified protein was 50 mg of tOmpA per liter of deu-
terated M9 minimal medium.
Mutagenesis, expression, and purification of Skp mutants
The QuikChange II mutagenesis protocol (Stratagene) was used to 
introduce the mutations A108L, A108R, A103L, A103R, or V117P 
into Skp. Polymerase chain reaction (PCR) primers (Table 2) were 
obtained from Microsynth. The expression and purification of the 
mutant proteins was performed as described for the WT proteins. 
The final yield of purified mutants was similar to WT.
Mouse infection model
Salmonella strains used in this study were based on S. enterica sero-
var Typhimurium SL1344 hisG xyl (51,  52). Salmonella mutants 
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with gene deletions were obtained by two consecutive single cross-
overs with positive selection for resistance to kanamycin and negative 
selection for levansucrase-mediated sensitivity to sucrose. Salmonella 
was grown in lysogeny broth containing NaCl (5 g/liter; “Lennox LB”). 
Each strain was transformed with a low-copy plasmid expressing 
a distinct fluorescent protein (mtagBFP2, mNeonGreen, YPet, or 
mCherry). These plasmids have no impact on in vivo fitness (53, 54). 
All animal experiments were approved (license 2239, Kantonales 
Veterinäramt Basel) and performed according to local guidelines 
(Tierschutz-Verordnung, Basel) and the Swiss animal protection law 
(Tierschutz-Gesetz). Eight 10- to 16-week-old female BALB/c mice 
(Charles River Laboratories) were infected by tail vein injection of 
mixtures containing WT Salmonella and different combinations of 
three mutants with about 1000 colony-forming units (CFU) each 
per strain. The exact inoculum size for each strain was determined 
by plating. After 4 days, mice were euthanized with carbon dioxide 
and Triton X-100 detergent–treated spleen homogenates were prepared 
as described previously (55). Total Salmonella loads were determined 
by plating dilution series on agar plates. Mutant-to-WT ratios were 
determined by flow cytometry counting of bacterial cells falling into 
gates indicative for the various fluorescent proteins using optical 
filters (55). Fitness was calculated as log2(FI), with FI corresponding 
to the fold increase starting from the initial spleen colonization 
[around 20% of the inoculum (56)] to the final spleen load for each 
strain. The relative fitness value of co-administered WT Salmonella 
was set to 100%. We also determined the more commonly used 
readout “competitive index” by dividing the output ratio (mutant/
WT) by the inoculum ratio (mutant/WT).
Complex assembly and aggregation assay
Complex assembly was carried out following a modified version of 
the protocol published by Burmann et al. (15). A 1.5 M excess of de-
natured tOmpA was added to Skp(WT) or mutants in 20 ml of as-
sembly buffer [20 mM MES (pH 6.5) and 150 mM NaCl] in a dropwise 
fashion under continuous stirring. The solution was then stirred for 
another 1 hour to ensure saturation of the chaperones. After centrif-
ugation at 10,000g for 30 min, the supernatant fraction, containing 
the Skp-tOmpA complexes, was separated from the pellet, contain-
ing the precipitated tOmpA. The supernatant was exchanged by 
ultrafiltration to NMR buffer [20 mM MES (pH 6.5) and 150 mM 
NaCl], and after concentration, the volume was adjusted to 250 l. 
The chaperone activity of Skp(WT) and mutant was determined 
by quantifying the NMR signals in 2D [15N,1H]-TROSY spectra 
of [U-2H,15N]-tOmpA bound to unlabeled Skp. Control sample of 
[U-2H,15N]-tOmpA in NMR buffer was prepared following the 
reference protocol, showing that, in the absence of the functional 
Skp(WT), less than 2% of [U-2H,15N]-tOmpA signals were observed 
in comparison to [U-2H,15N]-tOmpA bound to Skp(WT).
NMR spectroscopy
All NMR experiments for Skp-Omp complexes were performed in 
NMR buffer [20 mM MES (pH 6.5) and 150 mM NaCl]. The ex-
periments were recorded at the specified temperature on a Bruker 
AscendII 700 MHz or Avance 800 MHz spectrometer running 
Topspin 3.0 and equipped with a cryogenically cooled triple-resonance 
probe. For the sequence-specific backbone resonance assignment of 
[U-99% 2H, 13C, 15N]-Skp(A108L), the following NMR experiments 
were recorded at 37°C: 2D [15N,1H]-TROSY, 3D TROSY-HNCA, 3D 
TROSY-HNCACB, 3D TROSY-HNCO, and 3D TROSY-HN(CA)
CO. NMR data were processed with nmrPipe (57) and analyzed with 
CARA and ccpnmr (58). Secondary chemical shifts were calculated 
relative to the random-coil values of Kjaergaard and Poulsen (59). 
For the backbone assignment of the unfolded [U-2H,15N,13C]-Skp(WT), 
automated projection spectroscopy (APSY) experiments were re-
corded in NMR buffer [20 mM MES (pH 6.5) and 150 mM NaCl] 
containing 8 M urea at 15°C. The 5D APSY-HNCOCACB (60) was 
recorded with 54 transients for Skp, two scans per transient, 0.7-s 
recycle delay, and 1024 × 150 complex points in the direct and indi-
rect dimensions. The 4D APSY-HNCACB (60) was recorded with 
46 transients, two scans per transient, 0.7-s recycle delay, and 
1024 × 180 complex points in the direct and indirect dimensions, 
respectively. The GAPRO (geometric analysis of projections) (60) analysis 
of the projection spectra was carried out with υ = 5.0 Hz, Rmin = 
15.0 Hz, S/N = 7.0, and Smin,1 = Smin,2 = 8 for the 5D APSY-HNCOCACB and 
with υ = 5.0 Hz, Rmin = 15.0 Hz, S/N = 10.0, and Smin,1 = Smin,2 = 15 for the 
4D APSY- HNCACB. As the signals for glycine residues within the 
4D APSY- HNCACB and the signals of residues succeeding glycines 
within the 5D APSY-HNCOCAB have a different sign than the other 
resonances, the GAPRO algorithm was run twice for positive and nega-
tive peaks, respectively, and the two resulting peak lists were combined. 
The combined peak lists were assigned by using the newest version of 
the MATCH algorithm within the UNIO´10 software package, yielding 
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a 65% complete assignment for Skp. By using a conventional 3D 
TROSY-HNCACB experiment, complete backbone assignment for 
Skp could be obtained. NMR data were processed using PROSA (61) 
and analyzed with CARA and XEASY. Combined chemical shift 
differences of the amide resonances in 2D [15N,1H]-TROSY spectra 
were calculated as
  HN =  √ 
______________________
   ((   1H ) ) 
2
 +  (0.2 · (   15N ) ) 
2
(1)
Size-exclusion chromatography coupled to  
multi-angle light scattering
SEC-MALS measurements of Skp were performed at 25°C in NMR 
buffer [20 mM MES (pH 6.5) and 150 mM NaCl] using a GE 
Healthcare Superdex-200 Increase 10/300 GL column on an Agilent 
1260 high-performance liquid chromatography. Elution was moni-
tored using an Agilent multi-wavelength absorbance detector (data 
collected at 280 and 254 nm), a Wyatt Heleos II 8+ multiangle 
light-scattering detector, and a Wyatt Optilab rEX differential re-
fractive index detector. The column was equilibrated overnight in 
the running buffer to obtain stable baseline signals from the detectors 
before data collection. Inter-detector delay volumes, band broaden-
ing corrections, and light-scattering detector normalization were cal-
ibrated using an injection of bovine serum albumin solution (2 mg/ml; 
ThermoPierce) and standard protocols in ASTRA 6. Weight-averaged 
molar mass, elution concentration, and mass distributions of the sam-
ples were calculated using the ASTRA 6 software (Wyatt Technology).
Differential scanning calorimetry
DSC data were acquired using a Microcal VP-Capillary DSC instrument 
(Malvern Panalytical, Malvern UK) at a Skp trimer concentration of 
24.4 M (i.e., 73 M concentration in terms of monomer). After 
centrifugation, protein concentration was determined by ultraviolet 
spectrophotometry using a molar extinction coefficient of 4470 M−1 cm−1 
at 280 nm for the trimer and correcting for minor scattering contri-
butions to apparent absorbance. The Skp sample was scanned from 
15° to 105°C at a scan rate of 1°C/min, and data points were acquired 
at 0.1°C increments. Multiple buffer versus buffer scans, performed 
before the sample scan to establish the instrumental heat capacity base-
line, were averaged and subtracted from the sample scan data, which 
were then normalized to excess molar heat capacity using the trimer con-
centration. Attempts to fit the complex thermogram with standard 
models of oligomer dissociation and denaturation proved unsuccessful, 
so Cp for folding was estimated from the difference between the slopes 
of the excess molar heat capacity in low- and high-temperature re-
gions (the apparent pre- and post-transition baselines), fitted by 
linear regression, and extrapolated to the temperature of interest.
Description of the monomer-trimer equilibrium
The chemical equilibrium between trimeric and monomeric Skp 
can be described by the reaction
  3  S m ⇋  S t (2)
where the equilibrium constant L13 is given by
  L 13 =  
[ S t ] ─ 
 [ S m ] 3 
(3)
where [St] and [Sm] are the molar concentrations of Skp trimers 
and free Skp monomers, respectively, and L13 has units of M−2. For 
this equilibrium, the concentration of trimer [St] as a function of 
total Skp [S0] is given by Sandlin et al. (37)
  [ S t ] ([ S 0 ] ) =  
[ S 0 ] ─3 +  
 ─  
 ( √ 
_
  2 −   3 + ) 
 1 _3 
+  ( √ 
_
  2 −   3 + ) 
 1 _3 (4)
where , , and  are given by
         =  9  L 13  [ S 0 ] 
2 + 1 ─ L 13 
 (5)
   =   [ S 0 ] 
2  ─9 −  
 ─ 81 (6)
        =   [ S 0 ] 
3  ─18 −  
[ S 0 ]  ─ 162 (7)
The fraction of total Skp protein that is trimeric at any total Skp 
concentration equals
  f  S t  =  
3 [  S t ] ─[ S 0 ]
 (8)
and the fraction of total Skp protein that is monomeric equals
  f  S m  = 1 −  f  S t  (9)
SEC-MALS quantification of the trimeric and  
monomeric population
In SEC-MALS experiments in equilibrium situations, the detected 
molar mass represents the concentration-weighted average mass 
of the species involved
  M w =  
( c i  M i ) ─
( c i )
  (10)
where ci is the mass concentration and Mi is the molar mass of the 
ith species. Therefore, for the monomer-trimer equilibrium, by 
comparison with the limits for the completely monomeric or tri-
meric species, the weight-averaged mass reports directly on the 
fractional populations as
  f  S m  =  
 M obs −  M  S t   ─ M  S m  −  M  S t  
 (11)
where Mobs is the detected weight-averaged mass, and MSm and MSt 
are the detected masses of the completely monomeric and trimeric 
state, respectively.
NMR quantification of the trimeric and monomeric population
For the estimation of the population of monomeric and trimeric 
states for the WT and mutants, the residue lysine-141 was chosen, 
because its signals are well resolved in each state and it is located in 
a nonstructured, locally flexible region in the trimer. The fractions 
were estimated by calculating the ratio of the intensity of the signals 
in the monomeric and trimeric state according to the equation
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  f  S m  =  
 I  S m   ─  I  S m  +  I  S t  
(12)
where ISm and ISt are the intensity of the residue lysine-141 in the 
monomeric and trimeric state, respectively. Similarly, for the dena-
turation titration, the fractions of folded and unfolded Skp were 
determined from the signals of residue lysine-141, and for each 
titration point, G was calculated assuming a two-state model 
according to the equation
  G = − R ⋅ T ⋅ ln  
 f  S t   ─  f  S m  
(13)
The data were fitted by linear regression, and G was extrapolat-
ed to a concentration of 0 M urea.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/43/eabc5822/DC1
View/request a protocol for this paper from Bio-protocol.
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